WCM
GILD icon

Wedge Capital Management’s Gilead Sciences GILD Stock Holding History

Wedge Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$245K Sell
1,937
-203
-9% -$26.7K ﹤0.01% 466
2026
Q1 		$298K Sell
2,140
-215,571
-99% -$30.2M 0.01% 500
2025
Q4 		$26.7M Sell
217,711
-10,133
-4% -$1.23M 0.48% 92
2025
Q3 		$25.3M Sell
227,844
-59,085
-21% -$6.72M 0.43% 92
2025
Q2 		$31.8M Sell
286,929
-13,787
-5% -$1.47M 0.57% 72
2025
Q1 		$33.7M Sell
300,716
-12,509
-4% -$1.29M 0.65% 61
2024
Q4 		$28.9M Sell
313,225
-86,409
-22% -$7.78M 0.52% 68
2024
Q3 		$33.5M Buy
+399,634
New +$30.5M 0.58% 66
2022
Q1 		– Sell
-492,307
Closed -$35.7M – 432
2021
Q4 		$35.7M Buy
492,307
+54,756
+13% +$3.77M 0.44% 83
2021
Q3 		$30.6M Sell
437,551
-35,434
-7% -$2.49M 0.4% 86
2021
Q2 		$32.6M Sell
472,985
-9,133
-2% -$610K 0.4% 74
2021
Q1 		$31.2M Buy
+482,118
New +$31.1M 0.37% 121
2020
Q4 		– Sell
-423,873
Closed -$26.8M – 577
2020
Q3 		$26.8M Sell
423,873
-22,057
-5% -$1.53M 0.36% 106
2020
Q2 		$34.3M Buy
+445,930
New +$34.2M 0.47% 69
2020
Q1 		– Sell
-653,570
Closed -$42.5M – 550
2019
Q4 		$42.5M Buy
653,570
+138,778
+27% +$9.04M 0.47% 74
2019
Q3 		$32.6M Buy
514,792
+5,043
+1% +$330K 0.38% 102
2019
Q2 		$34.4M Sell
509,749
-94,220
-16% -$6.2M 0.39% 87
2019
Q1 		$39.3M Buy
603,969
+108,525
+22% +$7.21M 0.45% 79
2018
Q4 		$31M Buy
495,444
+20,887
+4% +$1.46M 0.38% 94
2018
Q3 		$36.6M Buy
+474,557
New +$35.8M 0.35% 77
2017
Q4 		– Sell
-535,474
Closed -$43.4M – 593
2017
Q3 		$43.4M Buy
+535,474
New +$40.9M 0.4% 69
2016
Q3 		– Sell
-572,650
Closed -$47.8M – 573
2016
Q2 		$47.8M Buy
572,650
+132,175
+30% +$11.7M 0.5% 63
2016
Q1 		$40.5M Buy
+440,475
New +$39.7M 0.42% 65

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Wedge Capital Management's GILD Position: Q2 2026 in Review

Wedge Capital Management reduced its Gilead Sciences (GILD) stake by 9.5% in Q2 2026, selling an estimated $26.7K and leaving 1,937 shares worth $245K. The position accounts for ﹤0.01% of the portfolio, ranked #466.

Wedge Capital Management first reported a position in GILD in Q1 2016 and has held it in 23 quarters since. The position peaked at $47.8M in Q2 2016. 534 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Wedge Capital Management held 1,937 shares of Gilead Sciences worth $245K as of Q2 2026.
  • Wedge Capital Management sold 203 Gilead Sciences shares in Q2 2026, an estimated $26.7K.
  • Gilead Sciences made up ﹤0.01% of Wedge Capital Management's portfolio in Q2 2026, its #466 holding.
  • Wedge Capital Management first reported a position in Gilead Sciences in Q1 2016 and has held it in 23 quarters since.
  • Wedge Capital Management's Gilead Sciences position peaked at $47.8M in Q2 2016.
  • 534 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Wedge Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.